Drawing for NORTHSHORE HEALTH

USPTO serial 90291198

NORTHSHORE HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCCARTHY, JOSEPH PATRICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NORTHSHORE HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew L. Goldstein

Andrew L. Goldstein Smith, Gambrell & Russell LLP311 S. Wacker DriveSuite 3000Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Genomic tests composed primarily of reagents for medical or clinical purposes; genomic tests for analyzing DNA information composed primarily of reagents for medical or clinical purposes; kits composed of reagents for use in genetic testing for medical or clinical purposesACTIVE—
035Providing referrals in the field of physician services; retail pharmacy servicesACTIVE—
036Charitable fundraising services in the field of medicineACTIVE—
038Providing access to databases that enable users to access patient diagnostic health information, medical reports, and educational information in the area of medicineACTIVE—
041Educational services, namely, providing courses of instruction in the field of medicine and healthcare through a medical school and providing continuing medical education coursesACTIVE—
042Medical and scientific research, namely, conducting clinical trials for others; Translational research, namely, medical research involving the translation of findings in scientific research to medical practice; providing scientific analysis and informational reports in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; reporting services based upon the results of laboratory testing in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; medical laboratory servicesACTIVE—
044Medical and health care services offered in hospital, ambulatory and outpatient settings, namely, hospital services, medical clinic services, medical clinics, physician services, home health care and hospice services, immediate and urgent medical care services, medical testing services for diagnostic or treatment purposes, and nursing care services; provision of home healthcare services; hospital and healthcare services; managed health care services; medical services; medical clinics; medical counseling services; providing medical profile and medical record analysis and assessments for diagnostic purposes; genetic testing for medical purposes; providing medical information, consultancy, and advisory services; preparation and generation of reports for medical diagnostic testing services; pharmacogenomics testing for diagnostic or treatment services; addiction treatment services in the field of substance abuse; psychiatric services; surgery; diagnostic and therapeutic radiology services; organ transplant services; treatment of sleep disorders; pain management treatment; providing an internet website portal in the field of medical and healthcare servicesACTIVE—
045Organizing and conducting support groups relating to health issuesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 4, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 4, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 19, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 19, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 19, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 14, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 12, 2023EX4GSOU EXTENSION 4 GRANTED—
Jun 12, 2023EXT4SOU EXTENSION 4 FILED—
Jun 12, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 25, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 25, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2022EX3GSOU EXTENSION 3 GRANTED—
Nov 15, 2022EXT3SOU EXTENSION 3 FILED—
Nov 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 14, 2022EX2GSOU EXTENSION 2 GRANTED—
Jul 14, 2022EXT2SOU EXTENSION 2 FILED—
Jul 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2022DOCKASSIGNED TO EXAMINER—
Jan 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2022EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2022EXT1SOU EXTENSION 1 FILED—
Jan 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 27, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 1, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 1, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 12, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 27, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 26, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2021DOCKASSIGNED TO EXAMINER—
Dec 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance